Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lalram Sangi"'
Autor:
Satheesh Chiradoni Thungappa, Hrishi Varayathu, Radheshyam Naik, Suhail Sayeed Mufti, Lalram Sangi, Vinu Sarathy, Priyank Tripathi, Beulah Elsa Thomas
Publikováno v:
Journal of cancer research and therapeutics. 17(1)
This study is an overall clinical analysis of anti-programmed cell death 1 (PD1) antibodies used in a single institution, emphasizing the role of baseline peripheral blood markers as a prognostic or predictor biomarker of immunotherapy.Sixty-one pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1bc37044dbe1561394e112c04be7957
https://pubmed.ncbi.nlm.nih.gov/33723141
https://pubmed.ncbi.nlm.nih.gov/33723141
Autor:
Goutham Kumar, Anju Murugan, Basavalinga S. Ajaikumar, Shalaka Somayaji, Smruthy Ann Mathew, Priyank Tripathi, Suhail Sayeed Mufti, Beulah Elsa Thomas, Radheshyam Naik, Lalram Sangi, Hephzibah Sara Mathew, Hrishi Varayathu, Sunny Kumar Gupta, Sonia Rani
Publikováno v:
Journal of Clinical Oncology. 39:e18802-e18802
e18802 Background: SAR, a known adverse event of cancer therapy has variable severity. Despite the availability of many approved grading tools, there is still a lack of a globally applicable grading system. To address this, World Allergy Organization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f79706616f4131113248e09feb67efaf
https://doi.org/10.1200/jco.2021.39.15_suppl.e18802
https://doi.org/10.1200/jco.2021.39.15_suppl.e18802
Autor:
Beulah Elsa Thomas, Mithua Ghosh, Gautam Balaram, Hrishi Varayathu, Lalram Sangi, Rashi Yogendranath Tiwari, Renjan Thomas, Sriniivas Bj, Vinayak Munirathnam, Radheshyam Naik, Suhail Sayeed Mufti, Basavalinga S. Ajaikumar, Shalaka Somayaji, Smruthy Ann Mathew, Satheesh Chiradoni Thungappa
Publikováno v:
Journal of Clinical Oncology. 39:e15020-e15020
e15020 Background: Neutrophil-Lymphocyte Ratio (NLR) and Lymphocyte-Monocyte Ratio (LMR) have been under scrutiny for their potential as a prognostic tool in various cancers. While there have been conflicting opinions on their reliability, NLR has sh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dadd25cccc6af8478e619016f20b5e7f
https://doi.org/10.1200/jco.2021.39.15_suppl.e15020
https://doi.org/10.1200/jco.2021.39.15_suppl.e15020
Autor:
Shalaka Somayaji, Beulah Elsa Thomas, Vinayak Munirathnam, Lalram Sangi, Samuel Luke Koramati, Basavalinga S. Ajaikumar, Satheesh Chiradoni Thungappa, Radheshyam Naik, Lalnun Puii, Tejaswini Bn, Smruthy Ann Mathew, Hrishi Varayathu, Shivakumar Swamy, Suhail Sayeed Mufti, Sriniivas Bj
Publikováno v:
Journal of Clinical Oncology. 39:e12570-e12570
e12570 Background: Gene expression profiling for breast cancer has classified ER positive subtype into luminal A and luminal B. Luminal B breast cancer (LBBC) have a higher proliferation and poorer prognosis than luminal A tumors. Ki-67 index is the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68ddffbd5ca8ede227535e04efa8b02f
https://doi.org/10.1200/jco.2021.39.15_suppl.e12570
https://doi.org/10.1200/jco.2021.39.15_suppl.e12570
Autor:
Hrishi Varayathu, Priyank Tripathi, Basavalinga S. Ajaikumar, Sonia Rani, Anju Murugan, Hephzibah Sara Mathew, Lincil Kurian, Radheshyam Naik, Shalaka Somayaji, Lalram Sangi, Suhail Sayeed Mufti, Beulah Elsa Thomas, Smruthy Ann Mathew, Sunny Kumar Gupta
Publikováno v:
Journal of Clinical Oncology. 39:e16269-e16269
e16269 Background: Combination of Gem+Nab-P is considered as a dose intense regimen which exhibits synergistic cytotoxic activity and equally effective in increasing survival as FOLFIRINOX regimen in pancreatic cancer. However, number of patients who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2bf1368a5a85438daae2beccf1b244a
https://doi.org/10.1200/jco.2021.39.15_suppl.e16269
https://doi.org/10.1200/jco.2021.39.15_suppl.e16269
Autor:
Diganta Hazarika, Radheshyam Naik, Tejaswini Bn, Lalram Sangi, Vinu Sarathy, Suhail Sayeed Mufti, Satheesh Chiradoni Thungappa, Beulah Elsa Thomas, Basavalinga S. Ajaikumar, Sriniivas Bj, Hrishi Varayathu, Shekar Patil, Lalnun Puii, Bhanu Prakash Lalkota
Publikováno v:
Journal of Clinical Oncology. 38:1078-1078
1078 Background: Androgen receptor (AR) expressing triple negative breast cancer (TNBC) is a sub-set of TNBC with an evolving prognostic and predictive behaviour. AR immunohistochemical threshold for positivity has not been standardized and a wide ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cf0a0823d424795f7e07bdb41d5029d
https://doi.org/10.1200/jco.2020.38.15_suppl.1078
https://doi.org/10.1200/jco.2020.38.15_suppl.1078
Autor:
Samuel Luke Koramati, Beulah Elsa Thomas, Suhail Sayeed Mufti, Smruthy Ann Mathew, Radheshyam Naik, Hrishi Varayathu, Satheesh Chiradoni Thungappa, Lalram Sangi, Vinu Sarathy, Lalnun Puii, Basavalinga S. Ajaikumar
Publikováno v:
Journal of Clinical Oncology. 38:e12579-e12579
e12579 Background: Metaplastic breast carcinoma is a rare histological subtype that has basal like characteristics and is reported to have a poorer prognosis than no specific type/ductal carcinoma (ductal/NST). We aimed to investigate clinicopatholog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebd5bafc5ae2d2b4492be5c4cd4edb0d
https://doi.org/10.1200/jco.2020.38.15_suppl.e12579
https://doi.org/10.1200/jco.2020.38.15_suppl.e12579
Autor:
Lalram Sangi, Vinu Sarathy, Radheshyam Naik, Hephzibah Sara Mathew, Dinesh S, Samuel Luke Koramati, Smruthy Ann Mathew, Basavalinga S. Ajaikumar, Shivakumar Swamy, Nitheesha Reddy, Beulah Elsa Thomas, Hrishi Varayathu, Santosh Elluru Kumar, Lalnun Puii, Suhail Sayeed Mufti
Publikováno v:
Journal of Clinical Oncology. 38:e15522-e15522
e15522 Background: Taxanes are an integral part of chemotherapy for a broad range of tumor types. The usual toxicities associated with Taxane use are peripheral neuropathy, myelosuppression and musculoskeletal adverse effects. Very few studies have r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97ad727cbf96a455f3d4bcad8cebecae
https://doi.org/10.1200/jco.2020.38.15_suppl.e15522
https://doi.org/10.1200/jco.2020.38.15_suppl.e15522